The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.
The landscape of drug discovery has been dramatically shifting, thanks in large part to the influence of artificial intelligence (AI).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback